Vivani Medical - 11 Year Stock Price History | VANI

Historical daily share price chart and data for Vivani Medical since 2014 adjusted for splits and dividends. The latest closing stock price for Vivani Medical as of April 30, 2025 is 1.03.
  • The all-time high Vivani Medical stock closing price was 566.40 on November 20, 2014.
  • The Vivani Medical 52-week high stock price is 2.09, which is 102.9% above the current share price.
  • The Vivani Medical 52-week low stock price is 0.91, which is 11.7% below the current share price.
  • The average Vivani Medical stock price for the last 52 weeks is 1.27.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Vivani Medical Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 1.1168 1.2000 1.2800 0.9600 1.0300 -11.21%
2024 1.4238 1.0400 4.2200 1.0100 1.1600 13.73%
2023 1.1077 0.8950 1.5700 0.8600 1.0200 20.00%
2022 3.9880 5.4900 7.7100 0.8500 0.8500 -82.62%
2021 13.1624 7.0500 46.4400 4.2900 4.8900 -12.83%
2020 5.6752 17.6880 18.1500 2.1900 5.6100 -68.50%
2019 19.8332 23.6400 27.3600 15.6480 17.8080 -16.25%
2018 40.0224 48.2400 55.4400 17.5200 21.2640 -53.61%
2017 31.9170 47.2800 66.2400 23.1360 45.8400 -3.05%
2016 91.0390 134.4000 162.9600 42.2400 47.2800 -66.55%
2015 255.1695 243.6000 418.5600 112.8000 141.3600 -42.59%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.061B $0.000B
Vivani Medical Inc. is the combination of Nano Precision Medical, Inc. and Second Sight Medical Products, Inc. The Company leverages proprietary technologies to develop and commercialize drug and device implants that treat patients with chronic diseases. Vivani Medical Inc., formerly known as Second Sight Medical Inc., is based in EMERYVILLE, Calif.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $93.202B 34.96
Zoetis (ZTS) United States $69.350B 26.25
Takeda Pharmaceutical (TAK) Japan $48.619B 10.76
Daiichi Sankyo, - (DSNKY) Japan $47.708B 24.27
Sandoz Group AG (SDZNY) Switzerland $19.609B 0.00
Astellas Pharma (ALPMY) Japan $18.241B 10.72
Merck (MKKGY) Germany $17.913B 14.82
Summit Therapeutics (SMMT) United States $17.424B 0.00
Shionogi (SGIOY) Japan $14.411B 14.44
United Therapeutics (UTHR) United States $13.508B 12.23
Neurocrine Biosciences (NBIX) United States $10.610B 32.60
IPSEN (IPSEY) France $9.463B 0.00
Orion OYJ (ORINY) Finland $8.841B 23.91
Corcept Therapeutics (CORT) United States $7.766B 59.06
Madrigal Pharmaceuticals (MDGL) United States $7.525B 0.00
Stevanato Group S.p.A (STVN) Italy $6.360B 40.38
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Grifols, S.A (GRFS) Spain $4.868B 0.00
Ionis Pharmaceuticals (IONS) United States $4.739B 0.00
Soleno Therapeutics (SLNO) United States $3.757B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.119B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.961B 12.02
Hypermarcas (HYPMY) Brazil $2.534B 16.67
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.402B 14.90
Recursion Pharmaceuticals (RXRX) United States $2.299B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.037B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.827B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.766B 0.00
Indivior (INDV) United States $1.620B 6.87
Guardian Pharmacy Services (GRDN) United States $1.525B 0.00
Evotec AG (EVO) Germany $1.516B 0.00
ARS Pharmaceuticals (SPRY) United States $1.366B 174.00
Dyne Therapeutics (DYN) United States $1.332B 0.00
Ocular Therapeutix (OCUL) United States $1.306B 0.00
Ardelyx (ARDX) United States $1.299B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.110B 45.11
Enliven Therapeutics (ELVN) United States $0.915B 0.00
Harrow (HROW) United States $0.905B 0.00
Collegium Pharmaceutical (COLL) United States $0.887B 4.71
Avadel Pharmaceuticals (AVDL) Ireland $0.832B 0.00
AleAnna (ANNA) United States $0.790B 0.00
Xencor (XNCR) United States $0.753B 0.00
Cronos Group (CRON) Canada $0.713B 0.00
Xeris Biopharma Holdings (XERS) United States $0.690B 0.00
KalVista Pharmaceuticals (KALV) United States $0.650B 0.00
Bioventus (BVS) United States $0.619B 16.08
Organogenesis (ORGO) United States $0.619B 0.00
Akebia Therapeutics (AKBA) United States $0.574B 0.00
Savara (SVRA) United States $0.563B 0.00
Relay Therapeutics (RLAY) United States $0.529B 0.00
USANA Health Sciences (USNA) United States $0.526B 11.29
Verve Therapeutics (VERV) United States $0.487B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.475B 0.00
Elite Pharmaceuticals (ELTP) United States $0.440B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.437B 0.00
Tourmaline Bio (TRML) United States $0.418B 0.00
Siga Technologies (SIGA) United States $0.412B 7.02
Zevra Therapeutics (ZVRA) United States $0.395B 0.00
Altimmune (ALT) United States $0.393B 0.00
Oruka Therapeutics (ORKA) United States $0.391B 0.00
Heron Therapeutics (HRTX) United States $0.356B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.350B 20.82
CytoDyn (CYDY) United States $0.316B 0.00
ProKidney (PROK) United States $0.316B 0.00
Aquestive Therapeutics (AQST) United States $0.282B 0.00
Avita Medical (RCEL) United States $0.264B 0.00
OmniAb (OABI) United States $0.226B 0.00
Regulus Therapeutics (RGLS) United States $0.223B 0.00
Nature's Sunshine Products (NATR) United States $0.221B 26.02
Wellgistics Health (WGRX) United States $0.209B 0.00
MediWound (MDWD) Israel $0.196B 0.00
Esperion Therapeutics (ESPR) United States $0.190B 24.00
Journey Medical (DERM) United States $0.174B 0.00
Inhibikase Therapeutics (IKT) United States $0.167B 0.00
Aldeyra Therapeutics (ALDX) United States $0.161B 0.00
Korro Bio (KRRO) United States $0.157B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.156B 0.00
Larimar Therapeutics (LRMR) United States $0.153B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.152B 47.01
4D Molecular Therapeutics (FDMT) United States $0.150B 0.00
Nanobiotix S.A (NBTX) France $0.148B 0.00
Profound Medical (PROF) Canada $0.147B 0.00
Aclaris Therapeutics (ACRS) United States $0.144B 0.00
Nektar Therapeutics (NKTR) United States $0.138B 0.00
Protara Therapeutics (TARA) United States $0.131B 0.00
Lyell Immunopharma (LYEL) United States $0.128B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lexeo Therapeutics (LXEO) United States $0.119B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.112B 0.00
Champions Oncology (CSBR) United States $0.104B 17.09
VAXART, INC (VXRT) United States $0.097B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
OptiNose (OPTN) United States $0.094B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.088B 0.00
Achieve Life Sciences (ACHV) Canada $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Context Therapeutics (CNTX) United States $0.079B 0.00
Galectin Therapeutics (GALT) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.079B 0.00
Unicycive Therapeutics (UNCY) United States $0.077B 0.00
Cassava Sciences (SAVA) United States $0.075B 0.00
Telomir Pharmaceuticals (TELO) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.068B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.068B 0.00
Inotiv (NOTV) United States $0.066B 0.00
Pyxis Oncology (PYXS) United States $0.064B 0.00
Nutriband (NTRB) United States $0.063B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Fractyl Health (GUTS) United States $0.062B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Karyopharm Therapeutics (KPTI) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
PMV Pharmaceuticals (PMVP) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Acrivon Therapeutics (ACRV) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.043B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.043B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
SCYNEXIS (SCYX) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Surrozen (SRZN) United States $0.034B 0.00
FibroGen (FGEN) United States $0.033B 0.00
PolyPid (PYPD) Israel $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
CASI Pharmaceuticals (CASI) China $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Mannatech (MTEX) United States $0.021B 8.29
DURECT (DRRX) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.019B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.016B 0.00
BioVie (BIVI) United States $0.015B 0.00
GlycoMimetics (GLYC) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.013B 0.00
Plus Therapeutics (PSTV) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 9.08
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.16
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Relmada Therapeutics (RLMD) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Talphera (TLPH) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Incannex Healthcare (IXHL) Australia $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00